» Articles » PMID: 15827156

Few Mutations in the 5' Leader Region Mediate Fitness Recovery of Debilitated Human Immunodeficiency Type 1 Viruses

Overview
Journal J Virol
Date 2005 Apr 14
PMID 15827156
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Repeated bottleneck passages of RNA viruses result in fitness losses due to the accumulation of deleterious mutations. In contrast, repeated transfers of large virus populations result in exponential fitness increases. Human immunodeficiency virus type 1 (HIV-1) manifested a drastic fitness loss after a limited number of plaque-to-plaque transfers in MT-4 cells. An analysis of the mutations associated with fitness loss in four debilitated clones revealed mutation frequencies in gag that were threefold higher than those in env. We now show an increase in the fitness of the debilitated HIV-1 clones by repeated passages of large populations. An analysis of the entire genomic nucleotide sequences of these populations showed that few mutations, from two to seven per clone, mediated fitness recovery. Eight of the 20 mutations affected coding regions, mainly by the introduction of nonsynonymous mutations (75%). However, most of the mutations accumulated during fitness recovery (12 of 20) were located in the 5' untranslated leader region of the genome, and more specifically, in the primer binding site (PBS) loop. Two of the viruses incorporated the same mutation in the primer activation signal in the PBS loop, which is critical for the tRNA3Lys-mediated initiation of reverse transcription. Moreover, 25% of the mutations observed were reversions. This fact, together with the presence of a large proportion of nonsynonymous replacements, may disclose the operation, during large population passages, of strong positive selection for optimal HIV-1 replication, which seems to be primarily affected by binding of the tRNA to the PBS and the initiation of reverse transcription.

Citing Articles

Genetic variability of the U5 and downstream sequence of major HIV-1 subtypes and circulating recombinant forms.

Mbondji-Wonje C, Dong M, Zhao J, Wang X, Nanfack A, Ragupathy V Sci Rep. 2020; 10(1):13214.

PMID: 32764600 PMC: 7411029. DOI: 10.1038/s41598-020-70083-1.


HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.

Sampathkumar R, Scott-Herridge J, Liang B, Kimani J, Plummer F, Luo M Viruses. 2018; 10(1).

PMID: 29295533 PMC: 5795417. DOI: 10.3390/v10010004.


Realistic three dimensional fitness landscapes generated by self organizing maps for the analysis of experimental HIV-1 evolution.

Lorenzo-Redondo R, Delgado S, Moran F, Lopez-Galindez C PLoS One. 2014; 9(2):e88579.

PMID: 24586344 PMC: 3938428. DOI: 10.1371/journal.pone.0088579.


In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.

Dalmau J, Codoner F, Erkizia I, Pino M, Pou C, Paredes R PLoS One. 2012; 7(2):e32714.

PMID: 22393441 PMC: 3290612. DOI: 10.1371/journal.pone.0032714.


FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection.

Murphy B, Vapniarsky N, Hillman C, Castillo D, McDonnel S, Moore P Retrovirology. 2012; 9:12.

PMID: 22314004 PMC: 3292463. DOI: 10.1186/1742-4690-9-12.


References
1.
Najera I, Holguin A, Quinones-Mateu M, Munoz-Fernandez M, Najera R, Lopez-Galindez C . Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J Virol. 1995; 69(1):23-31. PMC: 188544. DOI: 10.1128/JVI.69.1.23-31.1995. View

2.
Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, Deng H . In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med. 1997; 3(11):1259-65. DOI: 10.1038/nm1197-1259. View

3.
Seillier-Moiseiwitsch F, Margolin B, Swanstrom R . Genetic variability of the human immunodeficiency virus: statistical and biological issues. Annu Rev Genet. 1994; 28:559-96. DOI: 10.1146/annurev.ge.28.120194.003015. View

4.
Novella I, Duarte E, Elena S, Moya A, Domingo E, Holland J . Exponential increases of RNA virus fitness during large population transmissions. Proc Natl Acad Sci U S A. 1995; 92(13):5841-4. PMC: 41597. DOI: 10.1073/pnas.92.13.5841. View

5.
Lech W, Wang G, Yang Y, Chee Y, Dorman K, McCrae D . In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol. 1996; 70(3):2038-43. PMC: 190036. DOI: 10.1128/JVI.70.3.2038-2043.1996. View